Heidi Health raises $340M to expand its clinical AI beyond scribing
Melbourne-based Heidi Health raised $340 million: a $100 million Series C led by Blackbird at a $900 million valuation, plus $240 million in growth investment from General Catalyst. The company says its tools support 2.8 million patient visits a week in 190 countries. Its customers include Beth Israel Lahey Health and NHS England Midlands, which Heidi calls the largest clinical AI procurement in NHS history. Heidi plans to move from documentation into supervised, agent-style tasks it calls an AI Care Partner.
Why it's notable: This is one of the largest rounds yet for an ambient-scribe company outside the US leaders. It shows scribe vendors racing to take on more clinical and administrative work, which clinics will see in upcoming product and pricing choices.